Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit |
abx092223-100l |
Abbexa |
100 µl |
EUR 650 |
Human IgG antibody Laboratories manufactures the units s/c for sars igg test reagents distributed by Genprice. The Units S/C For Sars Igg Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Units products are available in stock. Specificity: Units Category: S/C Group: For Sars
Human Tuberculosis IgG (TB IgG) Rapid Test Kit |
Abbexa |
1 ml |
Ask for price |
Human Tuberculosis IgG (TB IgG) Rapid Test Kit |
Abbexa |
200 µl |
EUR 350 |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
Abbexa |
100 µl |
EUR 225 |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
Abbexa |
1 ml |
Ask for price |
Human Toxoplasma IgG (TOXO IgG) Rapid Test Kit |
Abbexa |
200 µl |
EUR 350 |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
Abbexa |
100 µl |
EUR 225 |
Human Cytomegalovirus IgG (CMV IgG) Rapid Test Kit |
Abbexa |
1 ml |
Ask for price |
For Sars information
SARS-CoV-2 Rapid Antigen Test Nasal |
9901-NCOV-03G |
Roche Diagnostics |
25 Tests/Kit |
EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
Monoclonal antibody to human IgG for rapid test |
MBS596150-1mg |
MyBiosource |
1mg |
EUR 480 |
Monoclonal antibody to human IgG for rapid test |
MBS596150-2mg |
MyBiosource |
2mg |
EUR 700 |
Monoclonal antibody to human IgG for rapid test |
MBS596150-5mg |
MyBiosource |
5mg |
EUR 1505 |
Spleen Colony-Forming Units (CFU-S) Inhibitor |
070-18 |
PHOENIX PEPTIDE |
500 μg |
EUR 73.44 |
SARS-CoV-2-Spike Antibody Rapid Test Kit |
abx090710-100l |
Abbexa |
100 µl |
EUR 650 |
SARS-CoV-2-Spike Antibody Rapid Test Kit |
abx090710-1ml |
Abbexa |
1 ml |
EUR 10500 |
SARS-CoV-2-Spike Antibody Rapid Test Kit |
abx090710-200l |
Abbexa |
200 µl |
EUR 2100 |
SARS S(C) |
sars-257 |
ProSpec Tany |
100µg |
EUR 165 |
Description: Recombinant SARS Associated Spike Mosaic S(C) |
Native Bovine Pancreatin: Lipase 8 USP units/mg Amylase 100 USP units/mg Protease 100 USP units/mg |
NATE-0503 |
Creative Enzymes |
1kg |
EUR 350 |
|
SARS-CoV-2 Neutralization Antibody Rapid Test Kit |
abx092242-100l |
Abbexa |
100 µl |
EUR 1925 |
SARS-CoV-2 Neutralization Antibody Rapid Test Kit |
abx092242-1ml |
Abbexa |
1 ml |
EUR 22500 |